Sun Pharmaceutical Industries Limited: Malnutrition trials

The registry lists 23 Malnutrition studies with Sun Pharmaceutical Industries Limited as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1No phase 22(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fed ConditionsCompletedNCT02311530Not applicable
• Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed ConditionsCompletedNCT02306902Not applicable
• Bioequivalence Study of Valsartan 320mg Tablets Under Fed ConditionsCompletedNCT02197494Not applicable
• Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fed ConditionsCompletedNCT01523119Not applicable
• A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fed ConditionCompletedNCT01513668Not applicable
• A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed ConditionsCompletedNCT01499771Phase 1
• A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fed ConditionCompletedNCT01222897Not applicable
• A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fed ConditionCompletedNCT01079078Not applicable
• Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5mL Under Fed ConditionCompletedNCT00951847Not applicable
• Bioequivalence Study of Topiramate Tablets 25mg Under Fed ConditionsCompletedNCT00902473Not applicable
• Bioequivalence Study of Sumatriptan 100mg Tablets Under Fed ConditionsCompletedNCT00872274Not applicable
• Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed ConditionsCompletedNCT00872235Not applicable
• Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed ConditionsCompletedNCT00845546Not applicable
• Bioequivalence Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fed ConditionsCompletedNCT00780013Not applicable
• Bioequivalence Study of Pseudoephedrine HCl 120 mg ER Tablets Under Fed ConditionsCompletedNCT00779805Not applicable
• Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed ConditionsCompletedNCT00779376Not applicable
• Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fed ConditionsCompletedNCT00778973Not applicable
• Bioequivalence Study of Nitrofurantoin 100 mg Capsules Under Fed ConditionsCompletedNCT00778583Not applicable
• Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg-42.9 mg/ 5 mL Oral Suspension Under Fed ConditionsCompletedNCT00778544Not applicable
• Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fed ConditionsCompletedNCT00778284Not applicable
• Bioequivalence Study of Glimepiride 1mg Tablets Under Fed ConditionsCompletedNCT00776620Not applicable
• Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed ConditionsCompletedNCT00775372Not applicable
• Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed ConditionsCompletedNCT00775359Not applicable